Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:cyclosporin A
go back to main search page
Accession:CHEBI:4031 term browser browse the term
Definition:A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle.
Synonyms:exact_synonym: 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
 related_synonym: (R-[R*,R*-(E)])-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl);   1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine];   30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;   Antibiotic S 7481F1;   Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl);   Cyclosporine;   Formula=C62H111N11O12;   Gengraf;   InChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42+,43-,44+,45-,46+,47+,49+,50-,51+,52-/m1/s1;   InChIKey=PMATZTZNYRCHOR-CGLBZJNRSA-N;   Neoral;   SMILES=CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\\C=C\\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C;   Sandimmune;   ciclosporin;   ciclosporina;   ciclosporine;   ciclosporinum
 alt_id: CHEBI:63586;   CHEBI:91802
 xref: Beilstein:3647785 "Beilstein";   CAS:59865-13-3 "ChemIDplus";   CAS:59865-13-3 "KEGG COMPOUND";   DrugBank:DB00091;   Drug_Central:760 "DrugCentral";   KEGG:C05086;   KEGG:D00184;   KNApSAcK:C00001517;   LINCS:LSM-1703
 xref_mesh: MESH:D016572
 xref: PMID:11058832 "Europe PMC";   PMID:11069928 "Europe PMC";   PMID:11079273 "Europe PMC";   PMID:11080188 "Europe PMC";   PMID:11238591 "Europe PMC";   PMID:11256490 "Europe PMC";   PMID:11278005 "Europe PMC";   PMID:11315347 "Europe PMC";   PMID:11370709 "Europe PMC";   PMID:11406057 "Europe PMC";   PMID:11426833 "Europe PMC";   PMID:11442023 "Europe PMC";   PMID:11481617 "Europe PMC";   PMID:11493684 "Europe PMC";   PMID:11529914 "Europe PMC";   PMID:11557554 "Europe PMC";   PMID:11564166 "Europe PMC";   PMID:11676831 "Europe PMC";   PMID:11870366 "Europe PMC";   PMID:12021257 "Europe PMC";   PMID:12050171 "Europe PMC";   PMID:12603598 "Europe PMC";   PMID:12761440 "Europe PMC";   PMID:12929192 "Europe PMC";   PMID:12950728 "Europe PMC";   PMID:14521916 "Europe PMC";   PMID:14621732 "Europe PMC";   PMID:14638917 "Europe PMC";   PMID:14672695 "Europe PMC";   PMID:14682659 "Europe PMC";   PMID:14743390 "Europe PMC";   PMID:15030555 "Europe PMC";   PMID:15175101 "Europe PMC";   PMID:15210365 "Europe PMC";   PMID:15306697 "Europe PMC";   PMID:15383526 "Europe PMC";   PMID:15541012 "Europe PMC";   PMID:15613074 "Europe PMC";   PMID:15626898 "Europe PMC";   PMID:15657176 "Europe PMC";   PMID:1566062 "Europe PMC";   PMID:15711594 "Europe PMC";   PMID:15811524 "Europe PMC";   PMID:15962181 "Europe PMC";   PMID:16372476 "Europe PMC";   PMID:16404634 "Europe PMC";   PMID:16724420 "Europe PMC";   PMID:16801218 "Europe PMC";   PMID:16898534 "Europe PMC";   PMID:17032751 "Europe PMC";   PMID:17083576 "Europe PMC";   PMID:17117422 "Europe PMC";   PMID:17192032 "Europe PMC";   PMID:17220244 "Europe PMC";   PMID:17229932 "Europe PMC";   PMID:17265451 "Europe PMC";   PMID:17446460 "Europe PMC";   PMID:17603747 "Europe PMC";   PMID:18076075 "Europe PMC";   PMID:18171316 "Europe PMC";   PMID:18191430 "Europe PMC";   PMID:18217899 "Europe PMC";   PMID:18259730 "Europe PMC";   PMID:18299432 "Europe PMC";   PMID:18359899 "Europe PMC";   PMID:18583716 "Europe PMC";   PMID:18597363 "Europe PMC";   PMID:18790203 "Europe PMC";   PMID:18818682 "Europe PMC";   PMID:18931077 "Europe PMC";   PMID:18975184 "Europe PMC";   PMID:19282398 "Europe PMC";   PMID:19589783 "Europe PMC";   Patent:US4117118;   Reaxys:3647785 "Reaxys";   VSDB:1765;   Wikipedia:Ciclosporin


show annotations for term's descendants       view all columns           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19669
    role 19613
      biological role 19611
        biochemical role 19138
          metabolite 19106
            cyclosporin A 8284
              cyclosporin A derivative + 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19669
    subatomic particle 19665
      composite particle 19665
        hadron 19665
          baryon 19665
            nucleon 19665
              atomic nucleus 19665
                atom 19665
                  main group element atom 19545
                    p-block element atom 19545
                      carbon group element atom 19428
                        carbon atom 19420
                          organic molecular entity 19420
                            organic group 18343
                              organic divalent group 18334
                                organodiyl group 18334
                                  carbonyl group 18222
                                    carbonyl compound 18222
                                      carboxylic acid 17923
                                        carboacyl group 16943
                                          univalent carboacyl group 16943
                                            carbamoyl group 16622
                                              carboxamide 16622
                                                peptide 9297
                                                  cyclic peptide 8704
                                                    homodetic cyclic peptide 8314
                                                      cyclosporin A 8284
                                                        cyclosporin A derivative + 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.